BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32735615)

  • 1. Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
    Supo-Escalante RR; Médico A; Gushiken E; Olivos-Ramírez GE; Quispe Y; Torres F; Zamudio M; Antiparra R; Amzel LM; Gilman RH; Sheen P; Zimic M
    PLoS One; 2020; 15(7):e0235643. PubMed ID: 32735615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Ferrer P; Gilman RH; López-Llano J; Fuentes P; Valencia E; Zimic MJ
    Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
    Zimic M; Sheen P; Quiliano M; Gutierrez A; Gilman RH
    Infect Genet Evol; 2010 Mar; 10(2):346-9. PubMed ID: 19963078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
    Yoon JH; Nam JS; Kim KJ; Ro YT
    World J Microbiol Biotechnol; 2014 Nov; 30(11):2821-8. PubMed ID: 25034468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
    Doustdar F; Pazhang M; Mehrnejad F; Safarzadeh M; Rabiei D; Chaparzadeh N; Falahati H; Mir-Derikvand M
    Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
    Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
    Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.
    Zhang H; Deng JY; Bi LJ; Zhou YF; Zhang ZP; Zhang CG; Zhang Y; Zhang XE
    FEBS J; 2008 Feb; 275(4):753-62. PubMed ID: 18201201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Mestdagh M; Fonteyne PA; Realini L; Rossau R; Jannes G; Mijs W; De Smet KA; Portaels F; Van den Eeckhout E
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2317-9. PubMed ID: 10471589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
    Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
    Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
    Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
    mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
    Petrella S; Gelus-Ziental N; Maudry A; Laurans C; Boudjelloul R; Sougakoff W
    PLoS One; 2011 Jan; 6(1):e15785. PubMed ID: 21283666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility.
    Vats C; Dhanjal J; Goyal S; Gupta A; Bharadvaja N; Grover A
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S14. PubMed ID: 25708048
    [No Abstract]   [Full Text] [Related]  

  • 14. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Aono A; Chikamatsu K; Yamada H; Kato T; Mitarai S
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4928-30. PubMed ID: 24867972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.
    Lemaitre N; Callebaut I; Frenois F; Jarlier V; Sougakoff W
    Biochem J; 2001 Feb; 353(Pt 3):453-8. PubMed ID: 11171040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system.
    Suzuki Y; Suzuki A; Tamaru A; Katsukawa C; Oda H
    J Clin Microbiol; 2002 Feb; 40(2):501-7. PubMed ID: 11825963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
    BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.
    Ando H; Mitarai S; Kondo Y; Suetake T; Sekiguchi JI; Kato S; Mori T; Kirikae T
    Clin Microbiol Infect; 2010 Aug; 16(8):1164-8. PubMed ID: 19832709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
    Scorpio A; Zhang Y
    Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.